How much is the fecal transplant therapy market worth, and how is it expected to expand?
The fecal transplant therapy market size has grown strongly in recent years. It will grow from $2.02 $ billion in 2024 to $2.15 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increasing awareness of fecal transplant procedures, high demand for advanced treatment, growing consciousness worldwide, rise in research and development investment, and the increasing prevalence of inflammatory bowel disease.
The fecal transplant therapy market size is expected to see strong growth in the next few years. It will grow to $2.71 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to the increasing adoption of biologics for the treatment, rising prevalence of chronic illnesses, increase in the use of biopesticides, growing prescriptions for novel drugs, and the increase in patients with target medical conditions. Major trends in the forecast period include increasing focus on microbiome research, development of synthetic alternatives, rise in clinical trials, advancements in delivery methods, and growth in donor screening.
Get Your Free Sample of The Global Fecal Transplant Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19431&type=smp
Which industry factors have accelerated the fecal transplant therapy market’s expansion?
The increasing prevalence of inflammatory bowel disease is expected to propel the growth of fecal transplant therapy markets going forward. Inflammatory bowel disease (IBD) is a chronic inflammation of the gastrointestinal tract, including conditions such as Crohn’s disease and ulcerative colitis. The rise in inflammatory bowel disease cases is due to increased consumption of highly processed foods, frequent or inappropriate use of antibiotics, improved hygiene, and reduced exposure to infectious agents in childhood. Fecal transplant therapy aims to restore a healthy gut microbiota, which helps mitigate inflammation and improve symptoms in patients with inflammatory bowel disease, potentially influencing its management and progression. For instance, in June 2023, according to Crohn’s and Colitis Canada, a Canada-based non-profit organization, there will be 470,000 inflammatory bowel disease (IBD) sufferers in Canada by 2035, up from an estimated 322,600 in 2023. Therefore, the increasing prevalence of inflammatory bowel disease is driving the growth of the fecal transplant therapy market.
What are the primary segments of the fecal transplant therapy market?
The fecal transplant therapymarket covered in this report is segmented –
1) By Procedure: Fecal Enema, Fecal Bacteriotherapy, Stool Transplant, Human Probiotic Infusion, Fecal Transfusion
2) By Disease: Clostridium Difficile Infection, Autism, Obesity, Parkinson’s Disease (PD), Diabetes Mellitus, Other Diseases
3) By End-User: Hospitals, Specialty Clinics, Other End-Users
Subsegments:
1) By Fecal Enema: Retention Enema, Cleansing Enema, Retention-Based Fecal Transplants, Home Administration Kits
2) By Fecal Bacteriotherapy: Suspension-Based Bacteriotherapy, Capsule Formulations, Customized Bacterial Preparations, Single Strain vs. Multi-Strain Products
3) By Stool Transplant: Direct Stool Transplant Procedures, Stool Suspension Transplant, Stool Capsule Transplant, Automated Stool Preparation Systems
4) By Human Probiotic Infusion: Single-Strain Probiotic Infusions, Multi-Strain Probiotic Infusions, Probiotic Blends With Prebiotics, Infusion Kits for Healthcare Providers
5) By Fecal Transfusion: Intravenous Fecal Transfusion, Transfusion via Gastrostomy Tube, Pre-Packaged Fecal Transfusion Solutions, Fecal Transfusion For Research Purposes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/fecal-transplant-therapy-global-market-report
Which firms are leading the fecal transplant therapy market?
Major companies operating in the fecal transplant therapy market are Mayo Clinic, Mount Sinai Health System Inc., Northwestern Medicine, NYU Langone Health, Michigan Medicine, UCLA Health, Duke University Health System Inc., Stanford Health Care, Ferring Pharmaceuticals, Cincinnati Children’s Hospital Medical Center, Emory Healthcare, Cambridge University Hospitals NHS Foundation Trust, Hamilton Health Sciences Corporation, Brigham and Women’s Faulkner Hospital Inc., Rebiotix Inc., Seres Therapeutics Inc., UPMC Hillman Cancer Center, OpenBiome, Center for Digestive Disease, BiomeBank Incorporated, The Regents of the University of California
Which market trends are set to define the future of the fecal transplant therapy market?
Major companies operating in the fecal transplant therapy market are focused on developing innovative therapies, such as pill forms of fecal microbiota transplantation (FMT) therapy, to enhance patient compliance and broaden the therapy’s accessibility. The pill form of fecal microbiota transplantation (FMT) therapy consists of encapsulated live bacteria from donor feces, designed to be taken orally. It aims to replenish healthy gut bacteria and improve intestinal health. For instance, in April 2023, Seres Therapeutics Inc., a US-based biotechnology company, and Nestlé Health Science S.A., a Switzerland-based healthcare company, launched VOWST. It is supplied as capsules, providing a convenient and less invasive treatment option to prevent recurrent clostridioides difficile infection (rCDI) in adults following antibacterial treatment. Unlike traditional fecal microbiota transplantation (FMT), which involves transferring whole stools, VOWST uses live bacterial spores of multiple Firmicute species derived from fecal microbiota from healthy human donors, believed to restore the gut microbiome.
Which geographic trends are shaping the fecal transplant therapy market, and which region has the highest market share?
North America was the largest region in the fecal transplant therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fecal transplant therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Fecal Transplant Therapy Market Report 2025 Offer?
The fecal transplant therapy market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Fecal transplant therapy, also known as fecal microbiota transplantation (FMT), is a medical procedure that involves the transfer of stool (feces) from a healthy donor into the gastrointestinal (GI) tract of a recipient. This treatment primarily addresses recurrent Clostridium difficile infections and other gut-related issues. It aims to repopulate the patient’s gut with beneficial bacteria to improve their health and digestion.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19431
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
